May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Regulation of VEGF Expression During Retinal Pigment Epithelial Cell Differentiation
Author Affiliations & Notes
  • K. M. Ford
    Schepens Eye Research Institute, Boston, Massachusetts
    Harvard Medical School, Boston, Massachusetts
  • B. A. Bryan
    Schepens Eye Research Institute, Boston, Massachusetts
    Harvard Medical School, Boston, Massachusetts
  • P. A. D'Amore
    Schepens Eye Research Institute, Boston, Massachusetts
    Harvard Medical School, Boston, Massachusetts
  • Footnotes
    Commercial Relationships  K.M. Ford, None; B.A. Bryan, None; P.A. D'Amore, None.
  • Footnotes
    Support  NIH Grants EY015435 and EY005318
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 860. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      K. M. Ford, B. A. Bryan, P. A. D'Amore; Regulation of VEGF Expression During Retinal Pigment Epithelial Cell Differentiation. Invest. Ophthalmol. Vis. Sci. 2008;49(13):860. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Despite a lack of active angiogenesis, VEGF is expressed in nearly all adult tissues. Recent evidence suggests that VEGF may serve as a survival factor for both vascular and non-vascular tissues. The mechanisms controlling constitutive VEGF expression in adult tissue are largely unknown; however, hypoxia, the best studied regulator of VEGF, is unlikely to be involved. Therefore, we sought to elucidate the molecular basis of VEGF regulation in adult tissues using differentiation models of mesenchymal (skeletal muscle) and epithelial (retinal pigment epithelium, RPE) cells.

Methods: : VEGF expression was analyzed using semi-quantitative PCR in proliferative and terminally differentiated C2C12 (myogenic progenitor) cells and in ARPE-19, a line of human RPE cells. The possible coordinate control of VEGF regulation during skeletal muscle differentiation was investigated in C2C12 cells by overexpressing a dominant negative form of the myogenic transcription factor (MyoD). In ARPE-19 cells, VEGF regulation was analyzed by transient transfection with luciferase reporter constructs containing varying lengths of the 9 kb VEGF promoter.

Results: : During skeletal muscle differentiation, upregulation of VEGF isoform expression coincided with cell differentiation; stable overexpression of a dominant negative MyoD suppressed VEGF expression. In ARPE-19 cells, the 9 kb VEGF promoter exhibited a 2000-fold increase in luciferase activity over the promoterless construct and a 10-fold induction over the 5 kb promoter. Sequence analysis of the region of the VEGF promoter between -5 kb and -9 kb revealed putative binding sites for Pax6, Otx2, and MITF, which are key transcription factors that are essential for RPE specification.

Conclusions: : The results in skeletal muscle indicate that VEGF is coordinately regulated with differentiation. Preliminary findings suggest that this paradigm may extend to the RPE. Elucidation of the mechanisms that regulate physiologic VEGF expression may permit the development of therapies that can control aberrant VEGF expression, as in the case of AMD, while sparing normal VEGF expression associated with vascular and neural cell survival.

Keywords: retinal pigment epithelium • differentiation • growth factors/growth factor receptors 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×